Spinelli, F., Conti, F., Caporali, R., Iannone, F., Cacciapaglia, F., & Rheumatology, o. b. o. t. S. C. o. t. I. S. o. (2023). Janus kinase inhibitors: Between prescription authorization and reimbursability. PAGEPress Publications.
Chicago Style (17th ed.) CitationSpinelli, F.R, F. Conti, R. Caporali, F. Iannone, F. Cacciapaglia, and on behalf of the Steering Committee of the Italian Society of Rheumatology. Janus Kinase Inhibitors: Between Prescription Authorization and Reimbursability. PAGEPress Publications, 2023.
MLA (9th ed.) CitationSpinelli, F.R, et al. Janus Kinase Inhibitors: Between Prescription Authorization and Reimbursability. PAGEPress Publications, 2023.
Warning: These citations may not always be 100% accurate.